Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment    

Global Neurology Devices Market

Neurology devices market is valued at $6566.23 million and will reach at $9946.1 million in 2018, with the CAGR of 6.6% during 2013- 2018.

The global neurology device market comprises submarkets such as Brain Monitoring Devices, Neurointerventional Devices and Nerve Repair & Regeneration. Amongst these Nerve Repair & Regeneration commanded the highest share of $1489.13 million in 2012 and will grow at 11.6 % annually during the period 2013-2018.

The major players in the global Neurology devices market are Covidien, PLC(Ireland), Stryker Corporation(U.S.), Johnson and Johnson (U.S.), Penumbra Inc. (U.S.).

What makes our report unique?

  • You can request 10% customization in the research matching your exact requirement for e.g. deep dive research in any specific geography or technology or applications.
  • This report provides competitive landscape of the top players. Under strategic benchmarking section, we will provide you their key developments along with the impacts including New Product development, M&A, strategic focus on any specific application, technology, and geography. Under Financial, we will provide you Capex (Investments), Revenues, EBITDA, etc. Under Operational insights, we will provide you new capacity added, New centers, new key employments. Under sales and marketing, we will provide you, insight on new contracts (available on public domain), new distribution channels added, new marketing initiatives, etc.

Key question answered

  • What are market estimates and forecasts; which markets are doing well and which are not?
  • What is the competitive landscape; who are the main players in each segment; what are their strategic directives, operational strengths, key selling products, and product pipelines?
  •  Who is doing what?

Audience for this report

  • Neurology Devices companies
show more
PRODUCT TITLE PUBLISHED
Nerve Repair & Regeneration Market Nerve Repair & Regeneration Market
Nerve Repair and Regeneration market was pegged at $4680.82 million in 2013 and expected to be $8112.19 million by 2018, growing at a CAGR of 11.6%. The neuromodulation market is the largest segment of $4.5 billion of overall Nerve Repair and Regeneration Market. Nerve Repair and Regeneration market segment includes direct nerve repair, nerve grafting, and stem cell therapy, while the neuromodulation segment includes internal stimulation devices such as Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), and external stimulation devices such as Transcranial Magnetic Stimulation (TMS) and Transcutaneous Electrical Nerve Stimulation (TENS). The main companies operating in peripheral nerve repair segment include Integra LifeSciences Corporation (U.S.), Stryker Corporation (U.S.), AxoGen, Inc. (U.S.), and Polyganics (The Netherlands). The key players in the neuromodulation segment include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.).
Upcoming
Global Neurostimulation/Neuromodulation Market Global Neurostimulation/Neuromodulation Market
 Global Neurostimulation/Neuromodulation market is expected to reach from $4503.9 million in 2013 to $7810.4 million by 2018 at a CAGR of 11.6%. The Neuromodulation market is the largest segment 96% of Nerve Repair & regeneration market. The market divided by 2 segments such as Internal Neuromodulation and External Neuromodulation. The internal neuromodulation devices market includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES), and external neuromodulation devices such as transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS). Major players in the market include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.).
Upcoming
North American Nerve Repair & Regeneration Market North American Nerve Repair & Regeneration Market
The North American Nerve Repair and Regeneration market was pegged at $2841.03 million in 2013 and expected to be $4709.59 million by 2018, growing at a CAGR of 10.6%. Nerve Repair and Regeneration market segment includes direct nerve repair, nerve grafting, and stem cell therapy, while the neuromodulation segment includes internal stimulation devices such as Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), and external stimulation devices such as Transcranial Magnetic Stimulation (TMS) and Transcutaneous Electrical Nerve Stimulation (TENS). The main companies operating The North American Nerve Repair and Regeneration market segment include Integra LifeSciences Corporation (U.S.), Stryker Corporation (U.S.), AxoGen, Inc. (U.S.), and Polyganics (The Netherlands). The key players in the neuromodulation segment include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.).
Apr 2015
European Nerve Repair & Regeneration Market European Nerve Repair & Regeneration Market
The nerve repair and regeneration market in Europe has displayed significant growth at a CAGR of 11.9%. Germany garnered the maximum market share and is expected to grow at a CAGR of 11.1%, followed by France and the U.K. 
Apr 2015
Asian Nerve Repair & Regeneration Market Asian Nerve Repair & Regeneration Market
The Asian Nerve Repair and Regeneration market was pegged at $4680.82 million in 2013 and expected to be $8112.19 million by 2018, growing at a CAGR of 11.6%. market segment includes direct nerve repair, nerve grafting, and stem cell therapy, while the neuromodulation segment includes internal stimulation devices such as Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), and external stimulation devices such as Transcranial Magnetic Stimulation (TMS) and Transcutaneous Electrical Nerve Stimulation (TENS). The main companies operating in peripheral nerve repair segment include Integra LifeSciences Corporation (U.S.), Stryker Corporation (U.S.), AxoGen, Inc. (U.S.), and Polyganics (The Netherlands). The key players in the neuromodulation segment include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.).  
Mar 2015
Asian Internal Neurostimulation Asian Internal Neurostimulation
The Asian internal neurostimulation market was $271.80 million in 2013, and expected to reach $546.6 million by 2018 at a CAGR of 15.0%. Internal Neurostimulation market segmented by 5 modalities includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES). Major players dominating the Internal Neurostimulation market are Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical (U.S.), Johnson & Johnson and Greenbatch Inc,.
Mar 2015
Global Internal Neurostimulation Market Global Internal Neurostimulation Market
The Internal Neurostimulation market was $3903.2 million in 2013 and expected to reach $6828.8 million by 2018 at a CAGR of 11.8%. The Internal Neuromodulation market is the largest segment 87% of Overall Neurostimulation/Neuromodulation market. Internal Neurostimulation market segmented by 5 modalities includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES). Major players dominating the Internal Neurostimulation market include Medtronic, Boston Scientific, St. Jude Medical, Cyberonics, Enteromedics, Neurotech, Cerebomed, Microtransponder and BioControl Medical.
Apr 2015
European Internal Neurostimulation European Internal Neurostimulation
The European internal neurostimulation market was $947.8 million in 2013, and is expected to reach $1715.8 million by 2018 at a CAGR of 13.0%. Internal Neurostimulation market segmented by 5 modalities includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES). Major players dominating the Internal Neurostimulation market are Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical (U.S), and Neuronetics, Inc (U.S.). Emerging players in this market include Biocontrol Medical, ANM Neuromodulation GmbH and Magstim Company Limited.
Upcoming
North American Internal Neurostimulation North American Internal Neurostimulation
The North American Internal Neurostimulation market was $2548.27 million in 2013 and expected to reach $4242.09 million by 2018 at a CAGR of 10.7%. Internal Neurostimulation market segmented by 5 modalities includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES). Major players dominating the Internal Neurostimulation market include Medtronic, Boston Scientific, St. Jude Medical, Cyberonics, Enteromedics, Neurotech, Cerebomed, Microtransponder and BioControl Medical.
Upcoming
Asian Neurostimulation/Neuromodulation devices Market Asian Neurostimulation/Neuromodulation devices Market
The Asian Neurostimulation/Neuromodulation market was expected to reach from $415.32 million in 2013 to $777.62 million by 2018 at a CAGR of 13.4%. The market divided by 2 segments such as Internal Neuromodulation and External Neuromodulation. The internal neuromodulation devices market includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES), and external neuromodulation devices such as transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS). Major players in the market include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.).
Upcoming
European Neurostimulation/Neuromodulation Devices Market European Neurostimulation/Neuromodulation Devices Market
The report also provides a detailed competitive landscaping of companies operating in this market. Segment- and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of major companies are detailed in the report. Boston Scientific (U.S.), Cyberonics (U.S), Medtronic, Inc. (U.S.), Depuy Synthes (Johnson & Johnson) (U.S.), and St. Jude Medical Inc. (U.S.) are some of the key players engaged in this market.
May 2015
North America Internal Neuromodulation Devices Market North America Internal Neuromodulation Devices Market
The North America neuromodulation market has been segmented by procedure, modality, and geography. On the basis of procedure, the market is further segmented into internal and external stimulation. The internal stimulation segment accounted for a share of 87.4% in the neuromodulation market. The market based on modality covers internal and external modality. The internal modality segment accounted for a share of 85.9% in the neuromodulation market.
May 2015
Brain Monitoring Devices Brain Monitoring Devices
The Global Brain Monitoring Devices Market, mainly driven by rising incidences of autoimmune and cardiovascular diseases, brain disorders and sleep disorders. The global brain monitoring market was valued at $1164.05 million in 2013 and is poised to grow at a CAGR of 8.6% to reach $1639.4 million by 2018. The Brain Monitoring Devices Market segmentation by products such as Electroencephalograph, Transcranial Doppler, Magnetoencephalograph, Intracranial Pressure Monitor, Cerebral Oximeter, and Acessories & by Application Sleep Disorders, Epilepsy, Traumatic Brain Injury, Brain Death. The main companies operating in Brain monitoring devices market and extensively covered in this report are Nihon Kohden Corporation, Nonin Medical Inc, Elekta AB, and Advanced Brain Monitoring, Inc., Yokogawa, Grass Technologies, Compumedics Ltd, Cadwell Laboratories
Upcoming
Neurointerventional Device Market Neurointerventional Device Market
The global Neurointerventional devices market is estimated to be $1544.79 million in 2013 and is expected to grow at a CAGR of 6.8% to reach $1944.7 million by 2018. The Neurointerventional  Devices market segmentation by 5 segments such as neurothrombectomy devices (suction/aspiration device, clot retriever, and snare device), cerebral angiography and stenting system (carotid stent, and embolic protection system), aneurysm coiling devices (platinum coil, liquid embolic agents, and flow diversion device) and support devices (microcatheter, and microguidewire). The major players operating in Neurointerventional device market and extensively covered in this report are Covidien, PLC (Ireland), Stryker Corporation (U.S.), Johnson & Johnson (U.S.), and Penumbra, Inc. (U.S.).
Upcoming
Electroencephalograph (EEG) Electroencephalograph (EEG)
The rising incidence of brain/mental disorders, along with the phenomenal growth of brain monitoring devices in Asia is expected to drive the rapid progression of the global electroencephalograph market. The global market is projected to grow at a CAGR of 9.8%, from 2013 to 2018. The market report provides insights into the market value forecasts, segmentation, drivers & restraints, opportunities for new entrants, and the competitive scenario in the market. North America, Europe, Asia, and RoW are the major regions considered for the extensive market analysis. 
Upcoming
Transcranial Dopplers (TCD) Transcranial Dopplers (TCD)
The growing investments in the healthcare sector, which aims to enhance mental healthcare delivery, along with the rising incidence of mental/brain disorders among the aging population in North America, Europe, and Japan are major driving factors of the global transcranial doppler market. The market report provides details of market segmentation, drivers & restraints, competitive scenario, and opportunities for new entrants. North America, Europe, Asia, and Rest of the World are geographical regions considered for market analysis. 
Upcoming
Magnetoencephalograph (MEG) Magnetoencephalograph (MEG)
The growing incidences of brain/mental disorders in the major regions of the world, along with increasing investments into research & development for brain monitoring devices, are the main drivers of the global magnetoencephalograph market. The North American segment is the largest contributor to the global market, having accounted for 52.27% in 2013. The Asian segment is expected to be the fastest-growing market segment, at a CAGR of 7.8% from 2013 to 2018. The report offers a comprehensive overview of market share, value chain analysis, and market metrics, such as drivers, restraints, and upcoming opportunities. North America, Europe, Asia, and Rest of the World are the main regions considered for the market analysis. 
Upcoming
Intracranial Pressure Monitors Intracranial Pressure Monitors
The Intracranial Pressure Monitors market was valued at $192.49 million in 2013, and is poised to grow at a CAGR of 7.4%, to reach $275.04 million by 2018. Major players in intracranial pressure monitors market are Integra Life Sciences Corporation (U.S.) and DePuy Synthes (U.S.) are the leading players in this market. The other prominent players are Spiegelberg GmbH (Germany), InnerSpace Neuro, Inc. (U.S.), and HeadSense Medical, Ltd. (Israel).
Upcoming
Cerebral Oximeters Cerebral Oximeters
The Global Cerebral Oximeters Devices Market is mainly driven by cardiac/vascular surgery, shoulder surgery, single lung ventilation, and various other surgical procedures. The global cerebral oximeters market was valued $80.42 million in 2013, and is estimated to reach $112.0 million by 2018, at a CAGR of 6.80%. The prominent players in the cerebral oximeters market are Covidien, PLC (Ireland), Nonin Medical (U.S.), and CAS Medical systems (U.S.).
Upcoming
Neurothrobectomy Devices Neurothrobectomy Devices
Neurothrobectomy Devices and Cerebral Ballon Angioplasty & Stenting Sytems,
Upcoming
91 reports | Show
Connect With Us
US/CAN : +1-888-502-0539